Yuko Palesch to Serum Albumin
This is a "connection" page, showing publications Yuko Palesch has written about Serum Albumin.
Connection Strength
0.417
-
High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013 Nov; 12(11):1049-58.
Score: 0.105
-
The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke. 2011 Jan; 42(1):119-27.
Score: 0.087
-
An electronic regulatory document management system for a clinical trial network. Contemp Clin Trials. 2010 Jan; 31(1):27-33.
Score: 0.080
-
The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. Biochem Soc Trans. 2006 Dec; 34(Pt 6):1323-6.
Score: 0.066
-
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis. Stroke. 2006 Aug; 37(8):2107-14.
Score: 0.064
-
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke. 2006 Aug; 37(8):2100-6.
Score: 0.016